Product Information
NEXIUM DR 2.5 MG PACKET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $9.1661 per EA under NDC 00186402501. Its NADAC has been published 568 times since Oct 21, 2015.
FDA first approved this application on Oct 20, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Esomeprazole magnesium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2.5 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00186402501
Classification
Brand
Dosage Form
GRANULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESOMEPRAZOLE MAGNESIUM TRIHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA021957FDA Approved
10/20/2006
TE Code
AB
On Market Since
6/1/2012
Pharmacological Classes
Price Statistics
The NADAC for NEXIUM DR 2.5 MG PACKET has been published 568 times since Oct 21, 2015, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.1661 per EA |
|---|---|
| All-time high | $9.2230 (Sep 11, 2024) |
| All-time low | $8.0819 (Oct 21, 2015) |
| 52-week high | $9.1849 |
| 52-week low | $9.1648 |
| Median price | $9.1661 |
| Average price | $8.9237 |
| Largest weekly change | +8.0% (Oct 12, 2016) |
| Weeks tracked | 568 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Esomeprazole magnesium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AstraZeneca Pharmaceuticals LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Esomeprazole magnesium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEXIUM DR 2.5 MG PACKET?
The current National Average Drug Acquisition Cost (NADAC) for NEXIUM DR 2.5 MG PACKET, manufactured by AstraZeneca Pharmaceuticals LP, is $9.1661 per EA (NDC 00186402501), effective Sep 30, 2026.
How has the price of NEXIUM DR 2.5 MG PACKET changed over time?
Over the history we have for it, the NADAC for NEXIUM DR 2.5 MG PACKET has risen 13.4%. It has been tracked across 568 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for NEXIUM DR 2.5 MG PACKET?
Since Oct 21, 2015, the NADAC for NEXIUM DR 2.5 MG PACKET has ranged from a low of $8.0819 (Oct 21, 2015) to a high of $9.2230 (Sep 11, 2024), with a median of $9.1661 per EA.
Are there cheaper alternatives to NEXIUM DR 2.5 MG PACKET?
No other NADAC-published product currently shares the active ingredient and strength of NEXIUM DR 2.5 MG PACKET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEXIUM DR 2.5 MG PACKET?
NEXIUM DR 2.5 MG PACKET (NDC 00186402501) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.